Premier Path Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-344
| Closed | -$218K | – | 396 |
|
|
2025
Q1 | $218K | Buy |
+344
| New | +$218K | 0.03% | 354 |
|
|
2024
Q4 | – | Sell |
-625
| Closed | -$657K | – | 384 |
|
|
2024
Q3 | $657K | Buy |
625
+5
| +0.8% | +$5.25K | 0.1% | 201 |
|
|
2024
Q2 | $651K | Buy |
620
+62
| +11% | +$65.1K | 0.11% | 188 |
|
|
2024
Q1 | $537K | Buy |
558
+42
| +8% | +$40.4K | 0.1% | 200 |
|
|
2023
Q4 | $453K | Buy |
+516
| New | +$453K | 0.1% | 202 |
|